Herbas VPB

Print
EN | LT
Supplementary protection
LT - Dolutegraviro ir lamivudino kompozicija ŽIV infekcijai gydyti
EN - COMBINATIONS OF DOLUTEGRAVIR AND LAMIVUDINE FOR THE TREATMENT OF HIV INFECTION
SPC
(11) Number of the document C 3494972
(68) Number of the document 3494972
(21) Application number for Supplementary Protection Certificate PA 2024 516
(22) Date of filing the application 2024-05-31
(41) Date of publication of the application 2024-06-25
Date of publication of SPC
(24) Date of coming into effect of SPC 2031-01-25
Applicant
(71) VIIV Healthcare Company , 251 Little Falls Drive, Wilmington, DE 19808, US
Grantee
(73) VIIV Healthcare Company , 251 Little Falls Drive, Wilmington, DE 19808, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/19/1370, 2019-07-01
Calculated date of expiry of the SPC
(94) 2034-07-03
Name of the product protected by the basic patent
(95) Dolutegraviras arba farmaciniu požiūriu priimtina druska, įskaitant dolutegraviro natrio druską ir lamivudiną
Legal status
SPC application published
Last update date 2025-07-28